KLP Kapitalforvaltning’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Hold
27,500
﹤0.01% 1601
2026
Q1
$204K Hold
27,500
﹤0.01% 1806
2025
Q4
$323K Hold
27,500
﹤0.01% 1626
2025
Q3
$212K Hold
27,500
﹤0.01% 1806
2025
Q2
$201K Hold
27,500
﹤0.01% 1784
2025
Q1
$261K Hold
27,500
﹤0.01% 1628
2024
Q4
$453K Buy
+27,500
New +$427K ﹤0.01% 1437

Other funds holding NEO

KLP Kapitalforvaltning's NEO Position: Q2 2026 in Review

KLP Kapitalforvaltning held its NeoGenomics (NEO) position steady in Q2 2026 at 27,500 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

KLP Kapitalforvaltning first reported a position in NEO in Q4 2024 and has held it in 7 quarters since. The position peaked at $453K in Q4 2024. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • KLP Kapitalforvaltning held 27,500 shares of NeoGenomics worth $401K as of Q2 2026.
  • KLP Kapitalforvaltning left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1601 holding.
  • KLP Kapitalforvaltning first reported a position in NeoGenomics in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's NeoGenomics position peaked at $453K in Q4 2024.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.